Physician profile
Brian Mosier
NPI 1538417274
$36,043.45
in general payments reported to CMS, 2019-2025
12 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,500 · 2020: $2,215 · 2021: $3,489 · 2022: $6,621 · 2023: $7,281 · 2024: $14K · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,650 · Travel and Lodging: $1,212 · Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,600.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,650.00 |
| Travel and Lodging | $1,211.61 |
| Food and Beverage | $756.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $30,426.53 | 2019-2024 | Maci |
| Mid-Atlantic Surgical Systems, LLC | $4,738.14 | 2019-2025 | |
| Innovation Technologies INC | $181.51 | 2019-2022 | |
| Arthrex, INC. | $153.88 | 2020-2025 | |
| Zimmer Biomet Holdings, INC. | $133.30 | 2023 | |
| Medtronic USA, INC. | $114.44 | 2020 | |
| Sanara Medtech INC. | $79.99 | 2025 | Celleraterx |
| Biocomposites INC | $73.32 | 2025 | Stimulan |
| Aesculap Biologics, LLC | $62.43 | 2022 | |
| Teleflex LLC | $31.45 | 2022 | |
| Heraeus Medical, LLC. | $26.80 | 2024 | |
| Smith+Nephew, INC. | $21.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mosier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.